Skip to main content

Table 10 Fecal Occult Blood (FOB)

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

Fecal Occult Blood (FOB) UP446
250 mgs
UP446
500 mgs
Celecoxib
200 mgs
Placebo
Visit Baseline Positive 0 0 0 0
  30 Days Positive 0 0 2 1
  90 Days Positive 3 5 5 4
Total per study period 3 5 7 5